We are live on ! Find out more

92 hedge funds and large institutions have $221M invested in Axogen in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

38% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 24

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

16% more capital invested

Capital invested by funds: $190M → $221M (+$30.6M)

5% more funds holding

Funds holding: 8892 (+4)

0.32% less ownership

Funds ownership: 64.2%63.88% (-0.32%)

98% less call options, than puts

Call options by funds: $2K | Put options by funds: $118K

Holders
92
Holders Change
+4
Holders Change %
+4.55%
% of All Funds
2.28%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
15
Increased
33
Reduced
24
Closed
6
Calls
$2K
Puts
$118K
Net Calls
-$116K
Net Calls Change
-$153K

AXGN Hedge Fund Activity: Q1 2017 in Review

92 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Axogen (AXGN) for Q1 2017, worth a combined $221M — up 16% from $190M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AXGN positions and 6 closed out — a net gain of 9 holders — while 33 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $13.3M. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $1.62M sold.

  • 92 institutional investors held Axogen (AXGN) as of Q1 2017, up from 88 in Q4 2016.
  • Funds reported $221M of Axogen stock for Q1 2017, up 16% quarter-over-quarter.
  • 15 funds opened new Axogen positions in Q1 2017 and 6 closed out, a net change of +9 holders.
  • The largest Axogen buyer in Q1 2017 was BlackRock, an estimated $13.3M added.
  • The largest Axogen seller in Q1 2017 was Bridgeway Capital Management, an estimated $1.62M sold.

Based on aggregated 13F filings for Q1 2017.